Four Plasmodium species cause malaria in humans. Most malaria-endemic regions feature mixed infections involving two or more of these species. Factors contributing to heterogeneous parasite species and disease distribution include differences in genetic polymorphisms underlying parasite drug resistance and host susceptibility, mosquito vector ecology and transmission seasonality. It is suggested that unknown factors limit mixed Plasmodium species infections, and that mixed-species infections protect against severe Plasmodium falciparum malaria. Careful examination of methods used to detect these parasites and interpretation of individual-and population-based data are necessary to understand the influence of mixed Plasmodium species infections on malarial disease. This should ensure that deployment of future antimalarial vaccines and drugs will be conducted in a safe and timely manner.
Although novel exceptions have been reported [1] , it is commonly agreed that Plasmodium falciparum, Plasmodium vivax, Plasmodium malariae and Plasmodium ovale are the four species that cause human malaria. Factors underlying mixed infections involving these parasite species have been discussed since 1930, when Knowles and White acknowledged difficulties that microscopists might encounter in accurately documenting their findings from examinations of blood smears [2] . Humans often harbor multiple Plasmodium species [3] [4] [5] [6] , and varying patterns in species-specific parasitemia and mixed-species prevalence characterize malaria infections in different endemic regions ( [7] [8] [9] [10] ; reviewed in Refs [11, 12] ). Data from malaria fever therapy patients involving different Plasmodium species [13] [14] [15] , and naturally infected study volunteers, have illustrated a range of observations from orderly to turbulent species-specific patterns ( Figure 1 ) of parasitemia in infected individuals [13] [14] [15] [16] [17] . Antimalarial treatment studies have also contributed insight regarding mixed Plasmodium species infections by revealing undocumented infection of a second species following successful treatment of a first species (reviewed in Ref. [18] ).
These varied patterns of parasitemia observed in individuals infected by multiple Plasmodium species are surely influenced by a complex array of host factors [19] acting to constrain the infection before the parasites completely over-run the available erythrocyte population. Evidence that the four Plasmodium parasites of humans antagonize one another seems less clear.
Conflicting results suggesting the presence or absence of mixed-species interactions from one study to the next are seldom resolved. If direct interaction between Plasmodium species occurs within an infected individual to any significant level, these interactions would then be expected to influence the distribution of species within the endemic population. A common theme discussed in the context of Plasmodium species interactions has focused on suppression of mixed infections. However, suppression of mixed-species infections is only one of the patterns found to characterize infection by multiple Plasmodium species in endemic human populations, as summarized by Richie [11] :
'As yet, no consistent evolutionary relationship between the species of human malaria parasites has emerged. I am led to conclude that there are geographical differences in the way in which human malaria species interact, and that these interactions may even change from year to year in a given locale. In summary, the strongest statement that can be made from the available data are that suppression or exclusion may occur between malaria parasites, but that these effects may be masked, particularly in regard to the prevalence of mixed infections, by factors such as heterogeneity in host susceptibility. ' It is possible that interactions among Plasmodium species infecting humans can influence efforts to develop future successful malaria control strategies in the ecologically diverse malaria-endemic settings. Thus, it is important to review the status of tools used to characterize malaria infections, as well as the interpretation of data generated by these tools and some of the practical issues that will continue to confront malaria control efforts. Identification of existing gaps in diagnostic technology, and consequently our knowledge of dynamic features of malaria infection (Box 1), will permit evaluation of how current limitations might influence our understanding of mixed Plasmodium species infections in humans. 104   10  20  40  60  80  100  120   10  20  30  50  70  90  110  130   30  50  70  90  110  130   40  60  80  100  120   98   100   102   106   10   100   1000 10 000
Parasitemia (IRBC m Plasmodium species diagnosis Blood-smear diagnosis is the most widely utilized approach for generating malaria infection data for epidemiological studies focused on mixed-species infections. In addition, PCR-based methodologies have introduced new strategies for malaria diagnosis worthy of consideration. Both techniques encounter qualitative and quantitative limitations. The blood-smear produces quantitative information and the range of parasitemia detected generally corresponds with clinical malaria. However, blood-smear microscopy reaches its limit of detection when parasitemia falls below 40 infected red blood cells (IRBC) per microliter of blood (10 8 total body parasites; Box 2), and the reproducibility of parasite counts and species identification is frequently inconsistent [20, 21] . Factors influencing the precision of blood-smear diagnosis include the quality of the blood slide preparation, the number of microscope fields analyzed (blood volume), and the microscopists' expertise. Furthermore, in regions of hypo-to meso-endemicity (Box 3), low parasitemia (!5 IRBC ml K1 ) can make species identification difficult. Each of these factors influence studies on mixed Plasmodium species infection and will affect diagnostic results from different endemic regions in different ways. These practical issues make it difficult to compare results of studies on mixed Plasmodium species infections within and between endemic regions.
In well-equipped laboratories, conventional PCR diagnosis of malaria is less constrained by operator expertise. The methods can be performed on hundreds of samples at a time in automation-ready formats (96-well plates), on samples archived for years under varying storage conditions, and encounters limits of detection only when parasitemia falls below 0.5 IRBC ml K1 (10 6 total body parasites). As mass production of sample processing introduces elements that improve uniformity of analysis, DNA extractions, PCR and detection reactions performed in 96-well plates using reagents prepared in volumes accommodating thousands of analyses favor improved precision and reproducibility of Plasmodium species diagnosis. Although PCR-based data have significantly changed perspectives on malaria epidemiology [3, 6, 22, 23] , diagnosis by these more-sensitive strategies does have limitations, for example: (i) PCR-based assays require expensive equipment and large quantities of disposable supplies; (ii) contamination can contribute to false positive results; (iii) until recently, PCR diagnostic assays have not provided species-specific enumeration of parasites; and (iv) DNA-based diagnostic strategies do not differentiate among the various developmental stages within infected erythrocytes and are not likely to detect blood-stage infection at its first onset (parasitemia, 5!10 K3 IRBC ml
K1
; 10 4 total body parasites) because of the sample volume assayed (w1 ml). Real-time PCR methodologies [24] (and other DNA-based strategies [25] ) provide quantitative data on the amount of species-specific templates within a sample; however, optimizing these diagnostic strategies requires significant expertise.
Alternative assays based upon commercially developed antigen-capture test kits have been designed primarily to diagnose P. falciparum. Target antigens include histidinerich protein 2 (HRP-2) [26] or Plasmodium lactate dehydrogenase (pLDH; live parasites) [27] . These assays are quick and easy to perform. However, limitations of the antigen-capture tests are encountered as they do not enable assessment of parasitemia and do not detect P. vivax, P. malariae or P. ovale specifically. Additionally, these assays are frequently less sensitive than microscopy, and can produce false positivity through detection of persistent antigenemia following parasite clearance (HRP-2) and through crossreactivity between HRP-2 and rheumatoid factor [28] .
Finally, P. falciparum presents unique challenges for enumerating blood-stage parasitemia in the infected human host because late-stage trophozoites and schizonts sequester in post-capillary venules. Some studies estimate that O75% of P. falciparum-infected erythrocytes are sequestered in the peripheral vasculature [29, 30] . Uncertainty related to the true level of P. falciparum sequestration could significantly influence quantitative estimates of species-specific parasitemia and present important challenges to modeling and interpretation of mixed Plasmodium species infections.
Infection dynamics
Human infection studies such as those performed during the era of the neurosyphilis trials [31] [32] [33] are not repeatable [34] ; however, these early patient studies contributed significantly to our ability to work with malaria parasites in research laboratories over the past 75 years, as well as to our understanding of the basic characteristics of human malaria infection [35] . To interpret mixed Plasmodium species infections, basic biological characteristics of infection by each species must be considered ( Figure 2 ). The minimum duration of liver-stage infection is 6 days (P. falciparum) [36] , 8-9 days (P. vivax and P. ovale) [36, 37] and 15 days (P. malariae) [38] . It is known that P. vivax produces a 'dormant' liver-stage infection through developmentally Limit of blood smear sensitivity arrested hypnozoites [39] . Relapses of P. vivax and P. ovale blood-stage infections, frequently observed to occur months after the primary blood-stage infections have resolved, are thought to result from activation of this specialized life-cycle stage [36, 39] . Curiously, although P. malariae is not known to produce hypnozoites, bloodstage infection by this species has been shown to reemerge following years of blood-smear negativity [36, 40] . The estimated number of merozoites produced by an infected hepatocyte varies from 30 000 (P. falciparum) to 10 000 (P. vivax) and 15 000 (P. malariae and P. ovale) [36] .
Plasmodium species have been observed to exhibit target cell population preferences. Whereas P. falciparum shows a preference for younger erythrocytes, it is capable of infecting erythrocytes of all ages [41] . By contrast, P. vivax and P. ovale are observed to prefer infection of reticulocytes [36, 42] , whereas P. malariae is suggested to prefer infection of mature erythrocytes [41] . During asexual blood-stage replication, the human Plasmodium species parasites produce tens of merozoites per infected cell (P. falciparum mean of 16, range 8-32; P. vivax mean of 16, range 12-24; P. malariae mean of 8, range 8-12; P. ovale mean of 8, range 4-16 [36] ). The pattern of fever and duration of the erythrocyte development cycle vary from 48 h (P. falciparum, P. vivax and P. ovale) to 72 h (P. malariae).
The parasite density provoking a fever (O37.3 8C) [43] , known as the pyrogenic density (PD), varies considerably from species to species: P. vivax and P. ovale induce fever at parasitemias around 100 IRBC ml K1 in non-immune adults [32] , and P. malariae induces fever at a parasitemia of around 500 IRBC ml K1 [43] . By contrast, P. falciparum induces fever at higher parasitemias of around 10 4 IRBC ml K1 [32, 43] . The parasitemia of P. falciparum infection is estimated to reach levels w100-fold higher than the other three human malaria parasite species and may exceed 10 5 IRBC ml K1 [32] . Whereas these values are observed to vary among endemic settings, across age ranges (PD decreases with age), and with level of malaria exposure [9, [44] [45] [46] , a consistent finding that the PD for P. falciparum is at least tenfold higher than the PD for P. vivax has been reported [9, 43] . As fever has been strongly associated with parasite killing in non-immune individuals [32] , this host response mechanism is considered to play an important role in regulating the rise and fall of parasitemia in infected individuals [47] . Interestingly, it has been suggested that the association between fever and changes in parasitemia may not be as strong in immune individuals [48] .
Examination of the salient quantitative differences distinguishing the human Plasmodium parasite species suggests that the 'playing field' is not level when these parasites compete for available erythroid target cells. On the basis of the species-specific characteristics reviewed above, the intra-individual infection landscape might appear to favor P. falciparum over the other Plasmodium species, and could translate into fluctuations between predominant and minority species within an endemic population. Although studies by Desowitz [49] and Cattani [50] provide evidence that P. falciparum overtakes the other malaria parasite species at a population level in Papua New Guinea (PNG), the evolution of chloroquine resistance in P. falciparum could have been the most important factor underlying this change. Despite this shift, and the other factors that might have been involved, the curious fact remains that the other three human malaria parasites are all commonly observed in infected individuals in PNG [6, 8, 23] . In contrast to Plasmodium species shifts in PNG, the prevalence of P. vivax malaria in South America has been increasing in recent years despite the co-prevalence of P. falciparum [51] . Therefore, the relationships between intra-individual and populationbased changes among the human Plasmodium parasite
Box 3. Malaria endemicity
Assessing levels of malaria endemicity is becoming the work of theoretical modeling based upon seasonal or annual variation in climate, vegetation, malaria prevalence, environmental factors that influence mosquito breeding and feeding behaviors, and human population data [69] . Field-based malariometric studies have employed the following spleen enlargement and/or parasite prevalence scale [72] . Holoendemic: Spleen or parasite prevalence O75% and prevalence of adult spleen enlargement is low. Parasite rates in the first year of life are high. Hyperendemic: Spleen or parasite prevalence 50-75% and prevalence of adult spleen enlargement is also high. Mesoendemic: Spleen or parasite prevalence 10-50%. Hypoendemic: Spleen or parasite prevalence 0-10%. Figure 2 . The characteristics of pre-erythrocytic and erythrocytic phases of parasitemia for different malaria species of humans. The blood smear kinetics shown here assume that a single sporozoite from different malaria species were used to infect humans, as indicated: Plasmodium falciparum (blue bar and circle), Plasmodium vivax (red bar and circle); Plasmodium ovale resembles P. vivax; and Plasmodium malariae (yellow bar and square). The minimum duration of liverstage infection is represented by blue (P. falciparum), red (P. vivaxand P. ovale), and yellow (P. malariae) bars. Key: E, elimination; M, parasitemia when malaria infection will be observed by conventional blood-smear analysis (2!10 8 total number of parasites in the body); PCR, parasitemia when malaria infection will be observed by PCR-based diagnosis (1 infected erythrocyte per 5!10 6 erythrocytes ml K1 ). species present further challenges that must be understood as vaccines and new strategies to control malaria are developed. A recent study [16] provides a new look at intraindividual Plasmodium species relationships through a longitudinal analysis of mixed-species infections in 34 children (ages 4-14 years) living near Madang, PNG. Beyond self-evident differences with malaria fever therapy studies, z50% of the PNG children were bloodsmear-positive for at least one Plasmodium species on the first day of the study, and so it is likely that all participants had experienced infection by one of the four human malaria species before the study. In addition, blood smears and clinical symptoms of the PNG children were evaluated on three-day intervals, not daily as shown in Figure 1 . The data from this PNG study provide examples showing that, when blood-smear parasitemia met with density-dependent constraints at or around 1000 parasites ml K1 (near the fever threshold in the same study population [44] ), parasitemia often, although not always, went below bloodsmear microscopy detection limits or resulted in a switch in the species formula (Pf:Pv:Pm) [16] . Bruce et al. interpret these findings to suggest that a relatively stable infection formula persists until a majority parasite population breaks through the threshold. At this point in the infection, mechanisms underlying a density-dependent regulatory force act against all infecting Plasmodium species and send the total parasitemia to some level below the threshold. Afterwards, the regulatory force is switched 'off ' and the parasite populations resume growth and replication. Although the biological mechanism(s) favored in this species-transcending density-dependent (STDD) regulation of malaria infection include components of the innate immune system augmented by elements of acquired immunity against former majority populations, it is also important to consider the influence of several host genetic polymorphisms when interpreting any individual's infection status or parasitemia.
Integrating what might be the expected influence of a STDD regulatory force on mixed-species infections and the distribution of parasites within endemic populations requires further consideration as the impact and durability of this force might affect what is observed in prevalence surveys. For example, if activation of the STDD force had a strong impact (Figure 3a) on the parasite population, it could drive the frequency of bloodsmear and PCR positivity below levels of detection, or eliminate infection. It has been, and continues to be, difficult for diagnostic methodologies to determine to what levels parasitemia falls (Figure 1) . Depending on the species-specific parasitemia following deactivation of the force, many more non-infected and single-species infections compared with mixed-species infections may be observed within the endemic population, consistent with the 'deficit' of mixed species infections reported by some [16, 52] . Alternatively, if the force is modest (Figure 3b) , parasitemia might not fall below microscopy and PCR detection limits, the combination of parasites infecting individuals might not change, and a higher number of mixed species infections would be found in the population. Although the data presented by Bruce et al. [16, 48, 53] illustrate that the STDD force is consistently durable in keeping parasitemia below 1000 IRBC ml K1 , study participants were seldom free of infection and PCR data suggested that infection complexity was higher by PCR than was reported by blood-smear diagnosis [16, 54] .
This latter interpretation of the STDD force would be consistent with our data from three individual malaria prevalence surveys [6, 23] conducted in Madang (Liksul) and East Sepik (Dreikikir and Wosera) Provinces in PNG. Evaluating 1242-2162 individuals, we compared numbers of non-infected, single-species infected and mixedspecies infected. Although we observed a deficit of mixed-species infections (single-species outnumbered mixed-species infections) by blood-smear, this deficit was reversed or substantially diminished when a subset of the population was evaluated by PCR [6, 23] . Furthermore, for both blood-smear-and PCR-based diagnostic results, chisquare analyses indicated that mixed-species infections in all three study populations were detected at, and not below (as might be implied by a deficit), their expected frequencies. This distribution of Plasmodium species within the endemic populations studied did not differ from an expected random distribution pattern and suggests no cross-species interactions. These studies, conducted in similar malaria-endemic regions of PNG, have focused on different aspects of mixed-species infections (intra-individual [16] and community-wide [6, 23] ) and have reached different conclusions regarding crossspecies interactions. Results appear to suggest that interactions among Plasmodium species within individuals do not influence the community-wide prevalence and distribution of Plasmodium species. From this, important practical questions arise in relation to vaccine development and evaluation of clinical malaria in regions where multiple Plasmodium species infect humans (Box 1, Gap 3 and Gap 4).
Immunological crossreactivity
Although early studies investigating mixed Plasmodium species interactions suggested that it might be possible for antigenic similarities between species to allow an individual vaccine molecule derived from one species to offer protection from the other human malaria parasites [55] , data to support this hypothesis have not been produced [56] . In fact, little if any cross-species immunity was observed during the malaria fever therapy trials, and individuals exposed to one Plasmodium species did not exhibit protection from high parasitemia or clinical malaria resulting from infection by a different Plasmodium species [33, 36, 57] . Primary P. malariae infection was associated with lower parasitemia and clinical disease in secondary P. falciparum malaria [33] . Reasons contributing to the illusive nature of cross-species immunity have become apparent, as low sequence similarity does not promote cross-Plasmodium species immune recognition despite similar antigen function, expression and localization. More specifically, studies characterizing the circumsporozoite proteins (CSPs) of human malaria parasites reported many amino acid sequence differences among P. falciparum (primary repeating amino acid motif NANP) [58] [VK247]) [59] , and P. malariae (NAAG) [60] . More recently, comparative studies have observed little homology among erythrocyte-binding proteins [61] . Specifically, del Portillo et al. reported that, although 17 out of 22 cysteine residues were similarly positioned between the P. vivax and P. falciparum merozoite surface antigens (MSA1/MSP1), there was only 35.6% amino acid identity between these species [62] . With continued progress on sequencing the Plasmodium species genomes [63, 64] , it might be possible for previously unidentified molecular homology between species to be identified and alter this working perspective.
Impact of mixed-species infection on malarial disease
Several different studies have now reported that P. vivax infections help to reduce the severity of P. falciparum malaria [65] [66] [67] [68] . The study conducted in Vanuatu [65] suggested that a C thalassemia might predispose young children to the more 'benign' P. vivax infection, which proves beneficial later when children become most susceptible to severe P. falciparum malaria. In studies from Thailand, Luxemburger et al. [66] reported that severe P. falciparum malaria was reduced from 5.7% (293 out of 5148) in patients infected with P. falciparum alone to 1.6% (10 out of 628) in patients with a P. falciparum-P. vivax co-infection. These authors suggest that fever induced at lower parasitemia by P. vivax (PD of w200 parasites per ml for P. vivax; 1500 parasites per ml for P. falciparum) might limit parasitemia and the pathogenic potential of P. falciparum. Smith et al. [67] have also suggested that P. vivax appeared to protect against P. falciparum disease in their studies in the Wosera region of PNG.
In addition, Price et al. [68] suggest that those with P. falciparum-P. vivax co-infection in Thailand showed less-severe anemia compared with individuals infected with P. falciparum alone. Although we have made similar observations in the Wosera (D. Tisch et al., unpublished), P. vivax contributed equally to anemia when compared with P. falciparum in single-species infections. As anemia is responsible for significant morbidity, and malaria is the second leading cause of hospitalization and death in PNG, it is difficult to conclude that constraints should be made against control of P. vivax malaria. As results of clinical malaria studies have largely been based upon blood-smear diagnosis of malaria infections, a more-sensitive diagnostic assay could reduce or nullify the apparent clinically protective effects associated with mixed Plasmodium species infections. 
Conclusion
We need to know more about mixed Plasmodium species infections because we know so little about the mechanisms regulating innate and acquired immunity against malaria in children under five years old, who bear the greatest risk of disease. As malaria affects humans at individual and population levels differently across environmentally varying regions [69] , it is important to encourage continued survey of malaria through both prevalence and longitudinal studies, and to improve diagnostic techniques so that species-specific parasitemia can be determined more efficiently and with greater precision. It is also important that assays capable of evaluating a wide range of immunological effector mechanisms from small amounts of blood should be developed. Along with improvement of laboratory methods for analyzing blood samples, any malaria survey study design should emphasize the importance of close interval sampling. Studies of this nature are likely to provoke discussions regarding the ethical conduct of research on vulnerable populations, particularly in individuals classified as 'non-immune'. However, without these studies, our understanding of the biological mechanisms that regulate mixed Plasmodium species infections in these regions will remain limited. These limitations have the potential to influence decisions on testing vaccines and new antimalarial drugs. Because clinical studies suggest that P. vivax infection in coendemic regions might decrease levels of P. falciparum parasitemia and severe pathogenesis, assumptions may follow that trials and deployment of P. vivax-specific vaccines or drugs [18, 70, 71] could lead to severe consequences of increased morbidity and mortality from P. falciparum malaria in treated regions. As many studies show that P. vivax represents a significant public health burden, forestalling tests on P. vivax-specific vaccines and drug strategies where mixed-species infections occur might prolong the impact of this parasite unnecessarily.
Roll Back Malaria: questioning the campaign
The Roll Back Malaria initiative (http://www.rbm.who.int/) was launched in 1998 with a pledge to slash the number of deaths from malaria in half by 2010. However, data from the World Health Reports 1999-2003 show that the annual number of malaria-induced deaths worldwide is now higher than it was when the campaign was first launched.
At this halfway stage, the question is now whether or not the initiative can be saved? The three main tools to fight malaria are already available -bednets, artemisinin-based combination therapy and insecticides -but their use needs to be made more widespread.
For more information, please go to: http://bmj.bmjjournals.com/cgi/content/full/328/7448/1086
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